KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death

Blood. 2014 Nov 20;124(22):3330-2. doi: 10.1182/blood-2014-09-598995.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / immunology*
  • Cytotoxicity, Immunologic*
  • Humans
  • Lymphocyte Activation*
  • Receptors, KIR3DL2 / metabolism
  • Receptors, KIR3DL2 / physiology*
  • Sezary Syndrome / immunology*
  • Sezary Syndrome / pathology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism*
  • T-Lymphocytes / pathology

Substances

  • KIR3DL2 protein, human
  • Receptors, KIR3DL2